Source: medcitynews.com Life sciences venture capital firm Flagship Pioneering is bringing a new preclinical startup focused on use of machine learning to discover new drugs out of stealth mode. The Cambridge, Massachusetts-based firm said Thursday that it had unveiled Generate Biomedicines, which it touts as being able to rapidly invent new drugs ranging from antibodies, peptides, enzymes, Read More